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Abstract
The ability to synthesize and salvage purines is crucial for colonization by a variety of human bacterial pathogens.
Helicobacter pylori colonizes the gastric epithelium of humans, yet its specific purine requirements are poorly understood,
and the transport mechanisms underlying purine uptake remain unknown. Using a fully defined synthetic growth medium,
we determined that H. pylori 26695 possesses a complete salvage pathway that allows for growth on any biological purine
nucleobase or nucleoside with the exception of xanthosine. Doubling times in this medium varied between 7 and 14 hours
depending on the purine source, with hypoxanthine, inosine and adenosine representing the purines utilized most
efficiently for growth. The ability to grow on adenine or adenosine was studied using enzyme assays, revealing deamination
of adenosine but not adenine by H. pylori 26695 cell lysates. Using mutant analysis we show that a strain lacking the gene
encoding a NupC homolog (HP1180) was growth-retarded in a defined medium supplemented with certain purines. This
strain was attenuated for uptake of radiolabeled adenosine, guanosine, and inosine, showing a role for this transporter in
uptake of purine nucleosides. Deletion of the GMP biosynthesis gene guaA had no discernible effect on mouse stomach
colonization, in contrast to findings in numerous bacterial pathogens. In this study we define a more comprehensive model
for purine acquisition and salvage in H. pylori that includes purine uptake by a NupC homolog and catabolism of adenosine
via adenosine deaminase.
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Introduction
The bacterial pathogen Helicobacter pylori is known for its ability
to colonize and persist in the human stomach, a niche that is
largely uninhabited by other bacteria. Infection by H. pylori greatly
increases the risk of duodenal and gastric ulcers, gastric cancers,
and MALT lymphoma [1]. As it infects between 20%–80% of the
adult population worldwide, H. pylori is regarded as one of the
most successful human pathogens [1]. One reason for this success
is that it has evolved for millennia in close association with humans
[2] and is well-adapted to acquire nutrients, including purines,
from the host gastric epithelium and from the mucus environment
[3,4]. Purines are critical for cellular growth and replication,
therefore it is important to examine the mechanisms by which H.
pylori acquires and salvages purines, and to determine the roles of
these pathways in host colonization.
It was recently shown that, in contrast to previous reports,
purines are absolutely required for growth of H. pylori 26695
(Abstract no. 2273, Miller, E. F. & Maier, R. J., Annual Meeting of
the American Society for Microbiology, May 2011), a result
confirmed for three other strains of H. pylori [5]. These
observations corroborate predictions made from the RAST-
annotated H. pylori genomes, which all lack the pathway for de
novo IMP synthesis [6]. H. pylori therefore relies on a purine salvage
pathway (Figure 1), which has been partially characterized already
[5,7,8]. Although several different strains were used for these prior
studies, the gene homologs for purine salvage are well-conserved
among the sequenced strains of H. pylori, making it likely that
purine utilization is similar across strains [6].
Here we study the purine requirements of H. pylori strain 26695,
for which, if a complete salvage pathway is present, any biological
purine base or nucleoside would suffice to support growth. It was
recently shown that all four biological purine bases (adenine,
guanine, hypoxanthine, or xanthine), as well as two nucleosides
(adenosine and guanosine) can individually serve as the sole purine
source for H. pylori strain G27 [5]. Nevertheless, purine
requirements for H. pylori have not been studied in a completely
defined medium, and it is also unclear which purines H. pylori uses
most efficiently. Historically, it has been challenging to study
specific nutrient requirements in this organism because most
minimal growth media include undefined biological supplements
such as bovine serum albumin (BSA) or foetal bovine serum (FBS)
[7,9,10]. However, with the recent optimization of a chemically
defined growth medium for H. pylori [11,12], the potential for
contaminating purines is eliminated and we can ask not only
which purines are sufficient for growth, but which are used most
efficiently.
If H. pylori can utilize any biological purine source including
adenine or adenosine, then it is surprising that H. pylori lacks
homologs to enzymes that can deaminate adenine or adenosine.
H. pylori cell extracts can convert radiolabeled adenine into
hypoxanthine, suggesting that adenine deaminase is the key
enzyme responsible for catabolizing AMP to IMP [13]. However,
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38727subsequent studies showed that a DdeoD mutant was unable to
grow on adenine as a sole purine source, implying instead that
adenosine deaminase is the responsible enzyme [5].
Another gap in our knowledge of H. pylori purine salvage is the
mechanism by which purines are transported into the cell. The H.
pylori protein HP1180 is homologous to the bacterial concentrative
nucleoside transporter (CNT) NupC, a H
+/nucleoside symporter.
The best-studied bacterial NupC proteins (from Escherichia coli and
Bacillus subtilis) transport pyrimidine rather than purine nucleosides
[14–16]. In H. pylori nothing is known about the substrate
specificity of HP1180, however its corresponding gene is co-
transcribed with phosphopentomutase (hp1179), and purine
nucleoside phosphorylase (hp1178) both of which are involved in
purine metabolism. We therefore predicted that this H. pylori
NupC homolog might play a role in purine uptake.
The overall aim of this study was to create a more precise
understanding of how H. pylori 26695 transports and metabolizes
purines, the efficiency to which each biological purine is used, and
the importance of purine conversions in host colonization.
Results
Growth of H. pylori in a synthetic medium supplemented
with various purine sources
H. pylori 26695 was grown in a modified version of Ham’s F12
(designated EMF12, Table S1). This medium does not represent
the minimum requirements for H. pylori growth, which are known
[12], but instead contains a wide array of vitamins and amino
acids in order to reduce the number of limiting components. In
addition, the salt and iron concentrations were modified as
described [12].
When grown in EMF12 supplemented with hypoxanthine, H.
pylori 26695 reached an average final OD600 of 0.1360.02
(approx. 8.1610
7 cfu/ml), which corresponded to three genera-
tions of growth (Figure 2). H. pylori grown in F12 generally achieves
a maximum growth yield of between 10
7–10
8 cfu/ml [12]. In the
absence of a purine source the optical density of the cell culture
decreased, confirming reports that H. pylori requires a purine
source for growth [5]. Serial dilutions were plated at 0 and
18 hours post-inoculation to verify that the number of cells in the
presence of hypoxanthine increased during log phase of growth
(data not shown). To further assess whether purine auxotrophy is
strain-specific, we grew two other wild-type strains, 43504 and
X47, under these same conditions and likewise observed growth
that was dependent on the presence of hypoxanthine (data not
shown).
To examine the ability of H. pylori 26695 to utilize a variety of
purine sources, we grew cells in EMF12 supplemented individually
with each of the following purines: hypoxanthine, adenine,
guanine, xanthine, and the four corresponding nucleosides inosine,
adenosine, guanosine, and xanthosine. With the exception of
xanthosine, all purines tested were capable of supporting growth.
The doubling time (Td) varied among the purine sources (Table 1),
and were longest (greater than 12 h) in media supplemented with
guanine, xanthine, or guanosine. Inoculum size affected growth in
the presence of certain purines. Hypoxanthine, adenine, inosine
and adenosine supported growth at a starting OD600 of 0.01
(10
6 cfu/ml), while growth on guanine, xanthine, or guanosine
required a minimum starting OD600 of 0.025 (2.6610
6 cfu/).
Figure 1. Overview of the current model for purine conversions in H. pylori. This network allows for salvage of purine nucleobases and
nucleosides, as well as inter-conversion between GMP and AMP. Color code: blue; enzymes that have been studied in H. pylori by mutant analysis
and/or biochemistry, green; enzymes for which genes have been identified, but whose role has not yet been confirmed, red; putative functional roles
whose genetic basis has not yet been identified. Abbreviations: GuaB, IMP dehydrogenase; GuaA, GMP synthetase; GuaC, GMP reductase; PurA,
adenylosuccinate synthetase; PurB, adenylosuccinate lyase; Gpt, hypoxanthine-guanine phosphoribosyl-transferase; Apt, adenine phosphoribosyl-
transferase; DeoD, purine nucleoside phosphorylase; PunB, purine nucleoside phosphorylase; Ade, adenine deaminase; Add, adenosine deaminase;
IMP, inosine monophosphate; XMP, xanthosine monophosphate; GMP, guanosine monophosphate; AMP, adenosine monophosphate.
doi:10.1371/journal.pone.0038727.g001
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growth; despite observing a slight increase in OD600 during the
first twelve hours after inoculation, viable cells were undetectable
after 12 hours. Attempts to enhance growth by increasing the
concentration of xanthosine to 1 mM or by increasing the initial
inoculum to 5610
6 cfu/ml were of no added benefit for
supporting growth (data not shown).
Growth of H. pylori 26695 gua and pur mutants in
a minimal medium
In most organisms, GMP is synthesized from IMP by the
enzymes IMP dehydrogenase (GuaB) and GMP synthetase
(GuaA), while adenylosuccinate synthetase (PurA) and adenylo-
succinate lyase (PurB) catalyze the formation of AMP from IMP
(Figure 1). The conversion of GMP back to IMP is carried out in
one step by GMP dehydrogenase (GuaC). H. pylori possesses
homologs for purA, purB, guaA, guaB, and guaC [17,18]. Recent
reports using H. pylori G27 showed that the gua and pur genes
perform similar roles in purine salvage as do their homologs in
other bacteria [5]. In order to confirm these results in H. pylori
26695, we constructed gene deletions in guaA, guaB, guaC, purA and
purB (Table S2, Materials and Methods). To study the phenotypes
of each mutant, strains were grown for 20 h in the chemically
defined medium EMF12 supplemented with one of seven different
purine sources (Figure 3). As predicted based on the canonical
purine conversion pathway outlined in Figure 1, strain EM202k
(guaA) required guanine or guanosine for significant growth (see
Figure 3 legend). EM203k (guaB) was able to utilize xanthine in
addition to guanine and guanosine as a sole purine source. EM204
(guaC) lacked the ability to degrade GMP back into IMP and
therefore grew in the presence of all purines except guanine,
guanosine, and xanthine. Similarly, strains EM205 (purA) and
EM206 (purB) grew only in the presence of exogenous adenine or
adenosine. These results support the conclusion that the gua and
pur genes are responsible for inter-conversion between GMP and
AMP in H. pylori.
H. pylori X47 DguaA is proficient for mouse colonization
Several bacterial pathogens rely on purine biosynthesis and
salvage genes for full virulence, in particular the gua genes [19–21],
and for this reason a strain lacking guaA was chosen to assess
whether the same is true for H. pylori. Strain EMX02k (DguaA) was
engineered using the mouse-adapted parent strain H. pylori X47
[22]. Prelimary growth studies were carried out in brain-heart
infusion (BHI), which, compared to EMF12, more closely
resembles conditions encountered in the host. The growth rate
of EMX02k in BHI was slower (Td=12.960.5 h) than the wild-
type (Td=5.560.2 h) (P,0.01, student’s t-test). The growth rate
of EMX02k was restored (Td=4.860.3 h) upon addition of 1 mM
guanosine to the medium.
Mice were inoculated with H. pylori X47 or EMX02k via oral
gavage, and infection was allowed to persist for three weeks before
sacrifice and enumeration of viable H. pylori from the homogenized
stomachs. Strain EMX02k was unattenuated for colonization as
compared to wild-type (p=0.45, Wilcoxon rank-sum test, n=8
mice per condition, Ho: no difference in colonization between
Figure 2. Growth of H. pylori 26695 in the chemically defined
medium EMF12. Liquid growth medium EMF12 was supplemented
with 60 mM hypoxanthine (solid line) or contained no purines (dashed
line). H. pylori cells were inoculated at an initial OD600 of 0.015 (approx.
1.3610
7 cfu/ml). Growth was monitored over time by measuring the
absorbance at 600 nm. Results are the mean 6 SD of three
independent cultures.
doi:10.1371/journal.pone.0038727.g002
Table 1. Growth rates and end-point yields of H. pylori grown
in EMF12 medium with various purine sources.
Purine source
Initial
OD600 Final OD600
a Td (h)
a
Generations
achieved
hypoxanthine 0.02 0.12960.01 7.361.6 2.6
adenine 0.02 0.12860.02 9.861.0 2.6
guanine 0.025 0.10660.02 12.862.8 2.0
xanthine 0.025 0.10460.04 12.462.8 2.0
inosine 0.02 0.13260.02 7.662.2 2.7
adenosine 0.02 0.12960.02 7.661.6 2.6
guanosine 0.025 0.10860.02 14.163.8 2.1
xanthosine 0.025 0.03960.01 NG
b ,1
aDoubling times were calculated using at least five data points taken during
exponential growth. Values are the mean 6 SD of three or more independent
experiments. Doubling times in guanine, xanthine and guanosine were
significantly longer than for hypoxanthine, inosine, or adenosine (student’s t-
test, P,0.05). Final OD600 values were not significantly different from one
another.
bNG = No growth observed after 36 hours.
doi:10.1371/journal.pone.0038727.t001
Figure 3. Growth of gua and pur mutants in EMF12 supple-
mented with individual purines. H. pylori strains were grown in
EMF12 supplemented with one of seven purine sources. After 20 hours,
the optical density was measured. Positive growth was defined as
a statistically significant increase in OD600 relative to the baseline OD600
of 0.025 (student’s t-test, P,0.05). Results are the mean 6 SD of three
independent growth cultures.
doi:10.1371/journal.pone.0038727.g003
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biosynthesis is not important for colonization by H. pylori.
Adenosine deaminase activity enables growth of H. pylori
26695 with adenine or adenosine as the sole purine
source
To better understand how H. pylori metabolizes adenine and
adenosine to satisfy its purine requirements, we measured
ammonium production by cell lysates in the presence of either
adenine or adenosine. While no ammonium was generated upon
incubating cell extracts (8 mg protein/ml) with adenine, in-
cubation with adenosine caused ammonium to increase linearly
over a period of 40 minutes. Reactions containing heat-killed cell
lysates in the presence of adenosine produced no increase in
ammonium over time, confirming that adenosine-dependent
ammonium production was indeed enzymatic. The observed
specific activity of adenosine deaminase in H. pylori cell lysates was
0.074 (60.03) mmoles NH4
+ min
21 mg
21 at pH 8.6, as de-
termined from the initial rate of ammonium production over time
from three independent experiments.
We further sought to test whether the adenosine deaminase
activity can vary depending upon the presence of adenosine in the
defined growth medium. There was no significant difference in
adenosine deaminase activity between cells grown in either
adenosine or hypoxanthine (data not shown), indicating that
under these conditions H. pylori does not regulate the production
and/or activity of this enzyme in response to changes in adenosine
availability.
H. pylori HP1180 aids in uptake of purine nucleosides
HP1180 from H. pylori 26695 is a member of the CNT family of
nucleoside transporters, and is present in all sequenced H. pylori
strains. An amino acid sequence alignment compares HP1180
against E. coli NupC (Figure 4). The latter protein transports
pyrimidine nucleosides and adenosine, but does not transport
guanosine or nucleobases, and transports inosine inefficiently [16].
Two other E. coli CNT transporters of unknown substrate
specificity YeiJ (NupX) and YeiM and are included in the
alignment.
HP1180 possesses conserved motifs (outlined in black boxes)
found in both prokaryotic and eukaryotic CNT transporters,
which supports its annotation as a NupC homolog. However,
HP1180 is actually more similar to the E. coli NupC paralogs YeiJ
(44% identical, 65% similar) and YeiM (45% identical, 64%
similar) than it is to NupC (28% identical, 52% similar).
Furthermore, we suspected that the co-expression of hp1180 with
purine-related genes point to a role for this NupC homolog in
purine uptake. We measured growth rates of a nupC deletion
mutant (EM207) in a defined medium containing individual
biological purine nucleobases and/or nucleosides. Strain EM207
exhibited a significantly longer doubling time compared to wild-
type in all purine supplements except adenine or adenosine
(Table 2). No growth was observed in media supplemented with
guanine, xanthine, or guanosine. These results indicate a role for
this NupC homolog in purine uptake.
We then directly measured purine nucleoside uptake using
radiolabeled substrates. Transport of [
14C]-adenosine, [
3H]-
inosine and [
3H]-guanosine was slower for strain EM207
compared to wild-type (Table 3). Furthermore, nucleoside uptake
by EM207 remained the same between the 5- and 20-minute time
points (P.0.25) in contrast to the wild-type, which after
20 minutes had taken up significantly higher levels of nucleoside.
These results support a role for this NupC homolog in purine
uptake, and suggest that HP1180 may be a non-redundant
transporter of purines in H. pylori.
Discussion
Similar to other pathogens that have evolved in close association
with their hosts [23–25], H. pylori does not have the ability to
synthesize purines de novo [5], a conclusion that our study
confirmed for H. pylori 26695 using a fully defined medium that
obviates the need for biological supplements typically added at
high concentrations (5% BSA and/or 10% FBS, for example). We
showed all individual biological purines except xanthosine allow
for growth, but certain nucleosides and nucleobases support faster
growth.
Guanosine supported the slowest growth among the purines
tested, while xanthosine failed to support growth at all. Similarly,
a strain of E. coli that cannot synthesize IMP de novo was severely
attenuated for growth in media containing xanthosine as a sole
purine source [26]. It is likely that the inability of H. pylori to grow
using xanthosine is attributed to either a deficiency for transport,
or a rate-limiting step in xanthosine utilization that cannot be
overcome.
In this study we confirmed recent reports identifying the genetic
basis for synthesis of GMP and AMP from the common
intermediate IMP [5]. Deletions in guaA, guaB, guaC, purA and
purB resulted in growth phenotypes that would be expected based
on the predicted functional roles for these genes. Surprisingly,
certain mutant strains (for example DpurA) achieved a higher
growth yield than wild-type in the presence of certain purines. It is
possible that certain gene deletions impart a growth advantage for
the organism, as was shown for a Lactobacillus lactis purine
auxotroph supplemented with inosine [27]. Alternatively, a com-
pensatory mutation may have occurred that enhanced the ability
of this strain to utilize one purine over another. Taken together
these data show that the genetic basis for conversion between
GMP and AMP in H. pylori 26695 is likely identical to the
conserved pathway used by most organisms.
We know that H. pylori can use adenine or adenosine to satisfy
its purine requirements, and that this phenotype relies upon
deamination of the adenine moiety into a hypoxanthine moiety.
Some prokaryotes (e.g. members of the phylum Firmicutes)
deaminate adenine directly via adenine deaminase [28], while
other bacteria possess adenosine deaminase. A third strategy is to
convert AMP into IMP by exploiting the histidine biosynthetic
pathway [29], however H. pylori lacks the necessary genes for
histidine biosynthesis and thus a histidine-purine connection does
not explain its ability to use adenine.
In contrast to previous reports of adenine deaminase activity in
H. pylori, [7], we detected hydrolysis of adenosine but not adenine
by H. pylori cell extracts. A recent study showed that the gene
encoding purine nucleoside phosphorylase (deoD) is required for
adenine utilization in H. pylori [5]. Other bacteria that rely on
adenosine deaminase to metabolize adenine also require by
necessity a nucleoside phosphorylase (see Figure 1) [30,31], thus
this phenotype is congruent with the presence of an H. pylori
adenosine deaminase. Although no homologs for adenosine
deaminase exist in H. pylori, it is possible that one of several
aminohydrolases – an enzyme family that is known to rapidly
evolve to accommodate novel substrates [32,33] – may serve as
adenosine deaminase in this organism.
H. pylori was shown previously to take up adenosine and
guanosine, as well as the nucleobases adenine, guanine and
hypoxanthine [13]. Our study is the first to examine a mechanism
for purine uptake by showing that a nupC mutant is deficient for
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Although previously studied bacterial NupC transporters are
pyrimidine-selective [15,16], these proteins represent one of two
broad phylogenetic clusters for bacterial CNTs: the second distinct
Figure 4. Sequence comparison between H. pylori NupC homolog (HP1180) and three E. coli CNT paralogs. Sequences for E. coli YeiJ
(GenBank
TM accession number AAA60513.1), E. coli YeiM (GenBank
TM accession number AAA60518.1), HP1180 (GenBank
TM accession number
AAD08224.1), and E. coli NupC (GenBank
TM accession number CAA52821.1) were aligned using ClustalW. Membrane-spanning helices were predicted
using the TMHMM program [46]. Conserved regions typical of CNT transporters are boxed in black [34].
doi:10.1371/journal.pone.0038727.g004
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Furthermore, certain eukaryotic CNT transporters can switch
from being pyrimidine-selective to purine-selective due to a single
amino acid substitution [35], highlighting the potential for CNT
transporters to evolve altered substrate preference.
To our surprise, the DnupC strain was growth-attenuated in the
presence of several nucleobases, indicating a role for HP1180 in
uptake of nucleobases. E. coli NupC does not transport nucleobases
[16], and therefore further studies are needed to resolve this
association between this H. pylori NupC homolog and nucleobase
utilization.
Many known pathogens require either guaA/guaB or purA/purB
for full virulence [19–21,36–38]. Surprisingly, our results suggest
that guaA has no effect on H. pylori colonization. It is possible that
guanosine and guanine are therefore not limiting for this pathogen
in vivo. Guanosine is the least abundant purine nucleoside in
human serum [39,40], however to our knowledge no studies have
measured purine concentrations in gastric mucus. It is noteworthy
that a certain proportion of H. pylori cells attach to gastric epithelial
cells during infection and can thus access nutrients from within
host cells [4]. Because purine concentrations are higher for
intracellular than for extracellular fluids [41,42], these epithelium-
associated bacteria may experience purine concentrations different
from that of bacteria inhabiting the mucus. Overall, these
colonization data suggest that guanine/guanosine are not limiting
for H. pylori growth in vivo. We now have a better understanding of
H. pylori’s ability to transport and salvage purines from the
environment, and the importance of purine salvage for virulence.
It would be relevant in the future to identify the genetic basis for
adenosine deaminase, as well as to characterize the H. pylori NupC
homolog for its precise transport function.
Materials and Methods
Strains and growth conditions
Helicobacter pylori strain ATCC 26695 was used as the parental
strain for physiology experiments. H. pylori strain X47 was the
parental strain for in vivo colonization studies. H. pylori were
routinely grown on Brucella Agar (Oxoid Ltd., Hampshire,
England) supplemented with 10% defibrinated sheep blood
(QuadFive, Ryegate, MT) (BA plates), and incubated in 37uC
incubator with gas concentrations maintained at 5% CO2,2 %O 2
and balanced N2. Plates were supplemented with 25 mg/ml
kanamycin or 30 mg/ml chloramphenicol as required. Liquid
cultures were grown in glass bottles with rubber or silicone
stoppers to minimize gas exchange. Cultures were grown at 37uC
and were aerated by shaking at 200 rpm. For growth in a rich
medium, Brain-Heart Infusion (Becton, Dickinson and Co.,
Sparks, MD, pH 7.4) supplemented with 0.4% b-cyclodextrin
(BHI) was used, and the initial gas concentrations (total pressure of
101 kPa) were: O2 (7%), CO2 (5%), H2 (10%) and N2 (78%).
EMF12 (pH 7.0) was used for studies of purine requirements (see
below for preparation). Initial gas concentrations for cells grown in
EMF12 were: O2 (20%), CO2 (10%), H2 (10%), and N2 (60%).
Preparation of EMF12 defined medium
The backbone recipe for EMF12 was previously described by
Ham (1965), and detailed instructions for its preparation can be
found therein [43]. Modifications to this original medium were
based on previously described optimization [12], and are specified
in Table S1. All components were dissolved in double-distilled
H2O. An exception to the original protocol outlined by Ham et al.
(1965) was the final pH adjustment, which was performed after the
addition of NaHCO3 rather than prior to. The purine source in
EMF12 varied according to the experiment, and was at
a concentration of 0.06 mM unless otherwise noted.
Construction of H. pylori deletion mutants
Overlapping PCR and allele-exchange mutagenesis was used to
generate deletion mutants. H. pylori 26695 genomic DNA was used
as a template to amplify an approximately 400 bp DNA fragment
both upstream and downstream of the target locus (Table S3).
Primers designated 1 and 2 (for example, guaA1 and guaA2) were
used to amplify the region upstream of the target locus, while
primers designated 3 and 4 (for example guaA3 and guaA4) were
used to amplify the region downstream of the target locus. The
aphA3 gene (encoding for kanamycin resistance) or the cat cassette
(encoding for chloramphenicol resistance) was amplified using
Table 2. Growth of EM207 (DnupC) in EMF12 supplemented
with a single purine source.
Purine source Td (h)
a
26695 (wild-type) EM207 (DnupC)
hypoxanthine 7.361.6 13.662.3*
adenine 9.861.0 9.760.1
guanine 12.862.8 NG
xanthine 12.462.8 NG
inosine 7.662.2 14.363.3*
adenosine 7.661.6 9.161.0
guanosine 14.163.8 NG
xanthosine NG
b NG
aThe initial OD600 was standardized to 0.025. Doubling times were calculated
using at least four data points taken during exponential growth. Results are the
mean 6 SD of three independent growth cultures from two independent
experiments.
*Significantly longer doubling times compared to wild-type (student’s t-test
P,0.05).
bNG = No growth observed after 36 hours.
doi:10.1371/journal.pone.0038727.t002
Table 3. Comparison of radiolabeled nucleoside uptake by H.
pylori 26695 versus EM207 (DnupC).
[
14C] adenosine uptake (cpm/10
8 cells)
a
5 min 20 min
26695 (wild-type) 137623 343642
Y
EM207 (DnupC)1 8 611
Q 4569*
[
3H] inosine uptake
(cpm/10
8 cells)
26695 (wild-type) 80616 210611
Y
EM207 (DnupC)2 0 6 6
Q 2567*
[
3H] guanosine uptake
(cpm/10
8 cells)
26695 (wild-type) 139626 449634
Y
EM207 (DnupC)3 9 615
Q 68630 *
aValues are the mean 6 SEM of four independent growth cultures. Trends were
similar among three independent experiments.
*Significantly lower uptake compared to wild-type (student’s t-test, P,0.01).
QSignificantly lower uptake compared to wild-type (student’s t-test, P,0.05).
YSignificant increase in nucleoside uptake for 20 min versus 5 min time point
(student’s t-test, P,0.05).
doi:10.1371/journal.pone.0038727.t003
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cassettes contain an upstream promoter and lack a transcription
termination sequences in order to avoid polar effects on
downstream genes. Primers 2 and 3 contain 59 end regions that
anneal to either end of aphA3 or cat, depending upon which
antibiotic marker is to be used in allelic exchange. Final
overlapping PCR reactions resulted in a sandwich fusion in which
the antibiotic resistance cassette is flanked by upstream and
downstream regions surrounding the gene locus. Following
excision and purification from an agarose gel, this PCR product
was introduced into H. pylori by natural transformation. Mutants
were then selected on BA plates containing kanamycin or
chloramphenicol as appropriate. Successful disruption of the
target allele was confirmed by PCR/gel electrophoresis and by
direct sequencing of the PCR fragment (Georgia Genomics
Facility).
Adenosine deaminase assay
The deamination of adenosine and/or adenine by H. pylori cell-
free extract was monitored by measuring the increase in
ammonium over time in the presence of either adenosine or
adenine. The reaction was initiated by the addition of 10 mg cell-
free extract to a reaction buffer containing 40 mM HEPES,
100 mM NaCl, 0.27 mM KCl, and 10 mM adenosine or adenine
(pH 8.6) at a final volume of 250 ml. The concentration of NH4
+
was measured at each time point using the phenol-hypochlorite
method [44], which monitors the absorbance at 625 nm as
compared to a standard curve of known ammonium concentra-
tions.
Nucleoside uptake assay
Radiolabeled [8-
14C]-adenosine, [8-
3H]-guanosine, and
[2,8-
3H]-inosine (Moravek Biochemicals Inc., Brea, CA), were
used in uptake assays. H. pylori 26695 cells were grown in BHI to
an OD600 of 0.2. Radiolabeled nucleosides were injected into the
bottles at a final concentration of 0.5 mCi/ml (for tritium-labeled
nucleosides) or 0.2 mCi/ml (for
14C-labeled adenosine) along with
20 mM unlabeled nucleoside. Bottles were shaken at 37uC, and
nucleoside uptake was measured at 5 min and 20 min using
a previously described method [45]. BHI containing radiolabeled
nucleosides but lacking cells was filtered and subtracted from all
experimental cpm values to account for substrate adhering to the
filter.
Mouse Colonization assay
H. pylori X47 or the isogenic mutant strain EMX02k were
grown for 24 hours on BA plates. 5–6 week-old female C57BL/
6NCr mice (NCI, Frederick, MD) were infected via oral gavage
with 0.2 ml of twice-washed bacterial cells suspended in PBS
(5610
7 H. pylori cells/mouse). Mice were sacrificed by CO2
asphyxiation and cervical dislocation three weeks after inoculation,
and stomachs were removed, weighed, and homogenized in PBS.
Samples of 100 ml from serial dilutions of the stomach homogenate
were spread onto BA plates containing amphotericin B (10 mg/
ml), vancomycin (10 mg/ml), and bacitracin (100 mg/ml). After
incubation at 37uC and 2% oxygen for 5–7 days, H. pylori colonies
were enumerated and colonization was expressed as cfu per gram
stomach tissue.
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